Wall Street Zen Downgrades Basel Medical Group (NASDAQ:BMGL) to Sell

Basel Medical Group (NASDAQ:BMGL) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday.

Basel Medical Group Trading Down 9.0%

BMGL opened at $2.43 on Friday. The company’s 50 day simple moving average is $3.54. Basel Medical Group has a one year low of $0.91 and a one year high of $9.40.

Basel Medical Group Company Profile

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement.